CLS

Q: What is the price of Celestica Inc. (CLS) today?

The current price of Celestica Inc. (CLS) is $ 401.74, representing a 385.37% gain over the past year. The stock began the year trading around $ 295.61 and is currently priced at $ 401.74. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Celestica Inc. (CLS) pay dividends?

Celestica Inc. (CLS) did not pay dividends over the past year.

Celestica Inc.

Price

$ 401.74

return (12m)

385.37%

p/e

54.70

p/bv

20.55

DIVIDEND YIELD

0.00%

CLS price

CLS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CLS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

40.01%

3 months

38.09%

1 year

385.37%

2 years

834.71%

5 years

0.00%

10 years

0.00%

Fundamentals CLS

review the fundamentals of Celestica Inc. shares

P/E

54.70

Sector: 8.17 Industry: 8.17

P/S (PSR)

3.68

Sector: 2.43 Industry: 2.43

P/BV

20.55

Sector: 2.13 Industry: 2.13

DIVIDEND YIELD (DY)

0.00%

Sector: 0.66% Industry: 0.66%

ROA

11.54%

Sector: 0.37% Industry: 0.37%

ROE

37.56%

Sector: 4.42% Industry: 4.42%

ROIC

41.20%

Sector: -75.43% Industry: -75.43%

NET MARGIN

6.72%

Sector: 3.02% Industry: 3.02%

GROSS MARGIN

12.06%

Sector: 32.11% Industry: 32.11%

OPERATING MARGIN

8.64%

Sector: 4.82% Industry: 4.82%

EV/EBITDA

37.59

Sector: 3.35 Industry: 3.35

EV/EBIT

43.97

Sector: 1.43 Industry: 1.43

PRICE-TO-ASSETS

6.31

Sector: 1.04 Industry: 1.04

BVPS

19.27

Sector: 9.54 Industry: 9.54

EPS

7.24

Sector: 0.71 Industry: 0.71

EQUITY-TO-ASSETS RATIO

0.31

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.69

Sector: 0.51 Industry: 0.51

CAGR REVENUE 5 YEARS

17.07%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

51.62%

Sector: - Industry: -

FAIR VALUE OF Celestica Inc. ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 401.74

Fair Value

$ 0.00

Upside/Downside Return potential.

-86.05%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CLS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	28.75	8.00	27.83%	0.31%	$ 1.74 T	30.08%
INTR	15.61	1.95	12.49%	1.34%	$ 3.71 B	15.62%
PBR	6.56	1.73	26.37%	5.83%	$ 131.78 B	22.13%
VALE	32.27	2.21	6.85%	5.70%	$ 75.90 B	6.12%
PLTR	215.03	46.67	21.70%	0.00%	$ 349.43 B	36.31%
SHEL	14.39	1.46	10.17%	3.29%	$ 256.67 B	6.68%
BDORY	11.32	0.79	6.98%	2.34%	$ 28.03 B	9.30%
MAIN	10.00	1.65	16.48%	7.24%	$ 4.93 B	83.37%
ENB	21.35	2.43	11.38%	5.17%	$ 114.82 B	11.49%
NSRGY	11.07	6.25	56.41%	3.37%	$ 259.11 B	10.91%
PBR-A	5.96	1.57	26.37%	5.79%	$ 119.79 B	22.13%
ITUB	13.51	2.78	20.61%	2.61%	$ 109.72 B	27.17%
UNH	24.40	2.89	11.85%	2.72%	$ 294.11 B	2.69%
BBSEY	8.41	7.22	85.85%	11.34%	$ 13.74 B	100.00%
SAN	12.50	1.53	12.24%	1.64%	$ 202.00 B	23.74%
TTE	14.71	1.64	11.17%	6.45%	$ 193.12 B	7.20%
RACE	36.10	0.00	0.00%	0.84%	$ 65.99 B	22.35%
TD	11.29	1.94	17.19%	2.86%	$ 176.99 B	34.54%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CLS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Celestica Inc.

Celestica Inc.

Average Investor10 user rating

4.0 (28 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Celestica Inc. (CLS) is a Canada-based company operating in the technology sector, within the electronics manufacturing services (EMS) industry. The company provides design, engineering, manufacturing, and supply-chain solutions for global clients across a wide range of industries.

Its business model is focused on delivering end-to-end production capabilities combined with engineering expertise and global logistics support.

Its activities include:

Product design and engineering services for electronic systems.
Electronic manufacturing and assembly operations.
Advanced testing and system integration solutions.
Supply-chain management and logistics services.
After-market support and lifecycle management.
Production of equipment for computing, networking, aerospace, and healthcare.

Celestica serves sectors such as technology, communications, aerospace, defense, healthcare, energy, and industrial markets. Its global operations span North America, Europe, and Asia, supported by manufacturing facilities, engineering centers, and supplier networks.

Market conditions influencing the business include demand for computing and networking infrastructure, supply-chain volatility, semiconductor availability, industrial digitalization, and competition within the global EMS industry.

Celestica is listed on the New York Stock Exchange under the ticker CLS.

History and Development

Celestica was founded in 1994, originating from the restructuring of IBM’s manufacturing operations in Canada as part of a broader shift toward outsourced production models.

The company expanded rapidly through acquisitions and increased its global footprint, establishing itself as a major EMS provider. Its IPO supported investments in capacity, engineering capabilities, and international operations.

Over time, Celestica transitioned from a volume-driven manufacturing model to a focus on higher-value, complex solutions across industries such as aerospace, healthcare, and industrial systems.

In recent years, the company has expanded into high-performance computing, renewable energy, and digital infrastructure, strengthening its position through automation, process innovation, and diversified end markets.

Additional Information

Celestica Inc. (United States) is listed on the Nasdaq and has a market capitalization of $45.54 Billions, with shareholders equity totaling $2.22 Billions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Celestica Inc. reported $12.39 Billions in revenue, generating net income of $832.50 Millions.

Key financial metrics include a P/E ratio of 54.70, a price-to-book (P/B) ratio of 20.55, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLS.

Market cap

$ 45.54 Billions

Net worth

$ 2.22 Billions

$ 2,216,300,000.00

Assets

$ 7.21 Billions

$ 7,213,100,000.00

Total Shares Outstanding

115.00 Millions

115,000,000

Average Daily Trading Volume

$ 2.15 Millions

$ 2,146,368.56

Sector

Others

Industry

Others

CLS

revenue by Business Segment Celestica Inc.

Revenue by Region Celestica Inc.

CLS revenue and profits

Financial Results CLS

DRAG THE FRAME TO SEE MORE DATA

CLS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 65.57 95,75% (12M)

P/E

0.01

2.28%

ROE

8.97%

P/BV

0.00

ALIZY - Allianz SE ADR

$ 45.58 17,20% (12M)

P/E

1.32

3.72%

ROE

67.54%

P/BV

0.89

CRERF - Carrefour SA

$ 19.40 41,66% (12M)

P/E

2.35

6.59%

ROE

11.14%

P/BV

0.26

UNH - UnitedHealth Group Incorporated

$ 353.52 --15,06% (12M)

P/E

24.40

2.72%

ROE

11.85%

P/BV

2.89

STLA - Stellantis NV

$ 8.50 2,81% (12M)

P/E

-1.23

8.29%

ROE

-32.04%

P/BV

0.39

COR - Cencora Inc.

$ 308.30 9,06% (12M)

P/E

39.10

0.70%

ROE

77.54%

P/BV

30.32

BLSH - Bullish

$ 43.31 --37,95% (12M)

P/E

-8.59

0.00%

ROE

-23.69%

P/BV

2.03

SHEL - Shell PLC ADR

$ 89.49 44,29% (12M)

P/E

14.39

3.29%

ROE

10.17%

P/BV

1.46